BioMarin Pharmaceutical (NASDAQ:BMRN)

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Apple, Biomarin, Corning, EA, FireEye, Grubhub, Nordstrom, NXP, Shopify, Xerox and More

Stocks managed to close marginally lower on Tuesday ahead of Wednesday's FOMC announcement, and the CME FedWatch Tool's 94.1% probability for a rate cut at the start of the week ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Acacia, Baidu, BioMarin, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P, Trimble, Visa, Zillow and More

Stocks were indicated to open slightly lower on Wednesday after Tuesday's equity trading recovered handily off the lows. All eyes will be on Federal Reserve Chair Jerome Powell's words on ...
Read Full Story »

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when ...
Read Full Story »

Citigroup Sees Big Upside for 2 of the Largest Biotechs

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

With 2019 well underway, and the first quarter almost over, many investors are resetting for what could be a more volatile rest of the year as the ongoing trade issues ...
Read Full Story »

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

With 2019 off and running and the first quarter now almost half over, many investors are resetting for what could be a more volatile remainder of the year as the ...
Read Full Story »

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

If most investors thought their portfolios took a beating during the final quarter of 2018, it was a good thing they were not all-in on the biotechnology segment. The VanEck ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Stocks entered the new year on a sour note, with equity futures down about 1.5% after weaker Chinese economic data. While investors used to buy every sell-off, the volatility in ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The futures traded down triple digits Friday morning as investors digested a very volatile trading week. Continued positive talk on trade, with China acknowledging the resumption of soybean and oil ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

Stocks were indicated to open marginally higher on Tuesday morning after a larger sell-off on Monday. Investors have been having less success buying the stock market dips in 2018 than in ...
Read Full Story »

Biopharma Companies to Watch This Week

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »